General Information
Drug ID
DR01333
Drug Name
Boceprevir
Synonyms
(1R,2S,5S)-N-(4-amino-1-cyclobutyl-3,4-dioxobutan-2-yl)-3-[N-(tert-butylcarbamoyl)-3-methyl-L-valyl]-6,6-dimethyl-3-azabicyclo[3.1.0]hexane-2-carboxamide; 3-{[(1R,2S,5S)-3-[(2S)-2-[(tert-butylcarbamoyl)amino]-3,3-dimethylbutanoyl]-6,6-dimethyl-3-azabicyclo[3.1.0]hexan-2-yl]formamido}-4-cyclobutyl-2-oxobutanamide; 394730-60-0; 89BT58KELH; Boceprevir; CHEBI:68621; EBP 520; SCH 503034; SCH-503034; UNII-89BT58KELH; Victrelis
Drug Type
Small molecular drug
Indication Hepatitis C virus infection [ICD11: 1E50.2, 1E51.1] Approved [1]
Structure
<iframe style="width: 300px; height: 300px;" frameborder="0" src="https://embed.molview.org/v1/?mode=balls&cid=10324367"></iframe>
3D MOL 2D MOL
Formula
C27H45N5O5
Canonical SMILES
CC1(C2C1C(N(C2)C(=O)C(C(C)(C)C)NC(=O)NC(C)(C)C)C(=O)NC(CC3CCC3)C(=O)C(=O)N)C
InChI
InChI=1S/C27H45N5O5/c1-25(2,3)20(30-24(37)31-26(4,5)6)23(36)32-13-15-17(27(15,7)8)18(32)22(35)29-16(19(33)21(28)34)12-14-10-9-11-14/h14-18,20H,9-13H2,1-8H3,(H2,28,34)(H,29,35)(H2,30,31,37)/t15-,16?,17-,18-,20+/m0/s1
InChIKey
LHHCSNFAOIFYRV-DOVBMPENSA-N
CAS Number
CAS 394730-60-0
Pharmaceutical Properties Molecular Weight 519.687 Topological Polar Surface Area 151
Heavy Atom Count 37 Rotatable Bond Count 10
Hydrogen Bond Donor Count 4 Hydrogen Bond Acceptor Count 5
PubChem CID
10324367
PubChem SID
15333889 , 22433429 , 22693607 , 41390184 , 46512784 , 57374555 , 57414843 , 79603721 , 92309409 , 96025559 , 103500897 , 109692987 , 134348397 , 135216213 , 137186019 , 137251857 , 139040316 , 152258143 , 160645839 , 160646982 , 162256796 , 163667336 , 164837112 , 175427026 , 175427127 , 176245990 , 180371765 , 198992422 , 223366205 , 223669397 , 226940314 , 245972903 , 249582863 , 251970943 , 252076908
ChEBI ID
CHEBI:68621
TTD Drug ID
D0V3YT
DT(s) Transporting This Drug P-GP Transporter Info P-glycoprotein 1 Substrate [2]
References
1 Boceprevir was approved by FDA. The official website of the U.S. Food and Drug Administration. (2019)
2 Drug interactions and protease inhibitors used in the treatment of hepatitis C: how to manage? Eur J Clin Pharmacol. 2014 Jul;70(7):775-89.

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.